MedPath

Prognostic Value of Sympathetic Modulation in Patients With Heart Failure

Conditions
Heart Failure
Registration Number
NCT02047409
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

The purpose of this study is to determine whether oscillatory pattern of sympathetic nerve activity muscle is an efficient index for the prognosis of patients with heart failure.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Patients with systolic heart failure and New York Heart Association (NYHA)
  • Ischemic, hypertensive, or idiopathic etiology
  • Left ventricular ejection fraction less than 40%
Exclusion Criteria
  • Neuromuscular, Orthopedic, Neurologic and Pulmonary Diseases
  • Renal failure
  • Diabetes mellitus type II

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peripheral autonomic control12 months

Evaluate if the reduction in the oscillatory pattern of muscle sympathetic nerve activity is associated with morbidity and mortality in patients with heart failure in a clinical follow-up 12 months

Secondary Outcome Measures
NameTimeMethod
Functional Capacity12 months
Arterial baroreflex control12 months
Blood inflammatory markers12 months
Cardiac and peripheral autonomic control12 months

Trial Locations

Locations (1)

Heart Institute (InCor), University of Sao Paulo, School of Medicine.

🇧🇷

São Paulo, Brazil

Heart Institute (InCor), University of Sao Paulo, School of Medicine.
🇧🇷São Paulo, Brazil
Edgar Toschi Dias, PhD
Contact
55 11 2661-5099
edgar.dias@incor.usp.br
Maria Urbana P B Rondon, PhD
Principal Investigator
Carlos Eduardo Negrão, PhD
Principal Investigator
Maria Janieire N N Alves, MD PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.